Standard Biotools Inc
Statements
Cash Flow
Standard Biotools Inc (LAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -10 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -11 | -8.5 | -8.3 | -8.0 | 0.7 | -16 | -4.3 | -4.1 | -0.6 | -20 | -5.0 | -4.5 | -5.5 | -4.3 | -2.8 | -4.6 | -3.7 | -13 | -15 | -9.5 | -7.0 | -16 | -30 | -25 | -19 | -8.5 | -9.3 | -11 | -14 | -62 | -39 | -28 | -14 | -30 | -21 | -22 | -1.2 | -47 | -10 | -80 | |
| 4.5 | 4.6 | 4.8 | 4.9 | 4.5 | 4.4 | 4.8 | 6.8 | 0.9 | 4.0 | 4.0 | 4.0 | 3.9 | 3.7 | 4.6 | 5.0 | 4.6 | 4.3 | 3.9 | 3.9 | 4.1 | 4.1 | 4.0 | 4.0 | 3.8 | 3.8 | 3.7 | 3.6 | 4.0 | 3.9 | 5.2 | 3.9 | 3.9 | 4.0 | 4.2 | 4.0 | 5.6 | 1.3 | 1.4 | 1.3 | 9.6 | |
| 3.6 | 2.8 | 2.4 | 2.3 | 2.3 | 2.0 | 1.7 | 2.0 | 2.3 | 5.0 | 2.3 | 3.0 | 3.0 | 3.1 | 2.4 | 3.6 | 4.4 | 4.1 | 3.7 | 3.7 | 4.3 | 4.4 | 4.0 | 4.7 | 4.5 | 1.7 | 3.1 | 3.1 | 3.4 | 3.5 | 3.6 | 6.7 | 5.9 | 7.5 | 9.0 | 5.4 | 7.5 | 5.7 | 8.8 | 4.1 | 26 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.7 | 4.6 | 5.1 | 53 | 38 | 9.1 | 1.0 | 2.4 | 4.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.6 | -0.2 | 1.6 | 1.7 | 1.2 | 4.7 | -9.4 | 3.1 | 1.7 | 2.2 | -12 | 1.9 | 1.3 | -4.2 | 0.5 | 0.2 | -9.0 | 5.3 | -2.3 | -6.3 | -2.3 | -5.8 | 3.1 | -2.5 | -5.5 | -2.2 | 1.3 | -0.7 | 1.7 | -1.6 | -10 | -4.0 | -11 | 8.7 | -16 | 0.0 | -1.2 | -31 | -55 | 46 | -41 | |
| 1.7 | 0.7 | 0.7 | 0.1 | 0.6 | 0.2 | 0.1 | 0.1 | 0.2 | 0.0 | 0.3 | 0.4 | 1.3 | 0.5 | 1.0 | 0.6 | 0.3 | 11 | 6.9 | 4.2 | 1.7 | 0.5 | 0.9 | 0.9 | 1.3 | 0.8 | 1.0 | 0.8 | 0.9 | 0.1 | 0.8 | 1.9 | 2.3 | 3.4 | 5.1 | 1.9 | 0.9 | 0.5 | 0.6 | 0.3 | 2.3 | |
| 9.8 | – | 18 | 3.6 | 0.4 | -3.9 | -0.3 | 4.2 | 0.8 | 0.0 | -9.8 | -36 | 6.5 | -0.6 | 17 | 10 | 13 | -0.8 | -4.9 | -4.2 | -1.7 | -1.1 | -0.9 | -138 | 11 | 40 | 43 | 40 | -50 | -13 | 318 | 50 | -31 | 26 | 15 | 28 | -6.7 | -11 | 191 | 14 | 188 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 13 | – | – | 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.1 | – | 0.0 | -0.1 | – | – | 0.0 | -0.1 | 0.0 | – | -0.1 | -0.4 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.5 | -1.0 | -0.1 | -0.1 | -0.1 | 0.0 | -0.1 | -0.6 | -2.5 | -2.4 | -0.4 | -0.2 | -11 | -29 | -0.1 | 0.0 | 0.0 | -0.2 | -0.1 | 0.0 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10 | 10 | 6.8 | 18 | – | -13 | – | – | – | – | – | – | – | 0.0 | -55 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | 29 | 0.2 | -0.1 | -2.1 | -0.1 | 60 | 0.1 | 1.0 | -0.2 | 1.8 | -0.5 | 0.5 | 20 | 0.4 | -1.0 | -0.1 | 9.8 | 7.3 | 18 | 213 | 0.0 | -0.3 | -2.6 | -2.1 | -1.2 | -1.0 | -20 | -28 | 0.0 | -55 | 0.0 | 0.1 | -0.1 | 0.6 | 0.0 | -0.1 | 0.3 | |
| -3.6 | 2.7 | 9.1 | -4.5 | 21 | -2.9 | -16 | -2.5 | -3.6 | 60 | -30 | -40 | 1.8 | -4.2 | 12 | 8.0 | 29 | -3.8 | -19 | -19 | -1.6 | -0.9 | 1.5 | 44 | -14 | 21 | 32 | 29 | -63 | -28 | 236 | -17 | -59 | -43 | -15 | 7.7 | -29 | -11 | 145 | 4.3 | 108 | |
| -15 | -11 | -9.2 | -8.4 | -8.5 | 0.4 | -16 | -4.4 | -4.3 | -0.7 | -20 | -5.4 | -5.9 | -6.0 | -5.3 | -3.4 | -4.9 | -14 | -20 | -19 | -11 | -7.5 | -16 | -31 | -26 | -20 | -9.5 | -10 | -12 | -14 | -63 | -41 | -30 | -17 | -35 | -23 | -23 | -1.7 | -47 | -11 | -83 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.